Yogi Pharmacy Limited
⚠️ High Risk
FEI: 1000600461 • Hardwar • INDIA
FEI Number
1000600461
Location
Hardwar
Country
INDIAAddress
29/30 Industrial Area, , Hardwar, , India
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 3/2/2020 | 64MDY99GONAD-STIMULATING PRINCIPLE N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/2/2020 | 64MDY99GONAD-STIMULATING PRINCIPLE N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/2/2020 | 64MDY99GONAD-STIMULATING PRINCIPLE N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/2/2020 | 64MDY99GONAD-STIMULATING PRINCIPLE N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/2/2020 | 64MDY99GONAD-STIMULATING PRINCIPLE N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/2/2020 | 64MDY99GONAD-STIMULATING PRINCIPLE N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/2/2020 | 64MDA99GONAD-STIMULATING PRINCIPLE N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/2/2020 | 64MDY99GONAD-STIMULATING PRINCIPLE N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/2/2020 | 64MDY99GONAD-STIMULATING PRINCIPLE N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/2/2020 | 64MDY99GONAD-STIMULATING PRINCIPLE N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/2/2020 | 64MDA99GONAD-STIMULATING PRINCIPLE N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/2/2020 | 64MDY99GONAD-STIMULATING PRINCIPLE N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/2/2020 | 64MDH99GONAD-STIMULATING PRINCIPLE N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/2/2020 | 64MDY99GONAD-STIMULATING PRINCIPLE N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/2/2020 | 64MDA99GONAD-STIMULATING PRINCIPLE N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
Frequently Asked Questions
What is Yogi Pharmacy Limited's FDA import refusal history?
Yogi Pharmacy Limited (FEI: 1000600461) has 15 FDA import refusal record(s) in our database, spanning from 3/2/2020 to 3/2/2020.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Yogi Pharmacy Limited's FEI number is 1000600461.
What types of violations has Yogi Pharmacy Limited received?
Yogi Pharmacy Limited has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Yogi Pharmacy Limited come from?
All FDA import refusal data for Yogi Pharmacy Limited is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.